What is carisoprodol, and how is it classified?
Carisoprodol is a prescription muscle relaxant. It is classified in the United States as a centrally acting skeletal muscle relaxant used to relieve muscle pain and discomfort.
Is carisoprodol a controlled substance?
Yes. In the United States, carisoprodol is classified as a Schedule IV controlled substance. That scheduling reflects its potential for misuse and dependence.
What is the typical drug class/categorization used on prescriptions?
On formularies and pharmacy records, carisoprodol is commonly categorized under “muscle relaxants” (specifically a centrally acting muscle relaxant), and it may also show up as “controlled substance (Schedule IV)” due to federal regulation.
Why does the classification matter for patients?
Because it is Schedule IV, carisoprodol is subject to tighter prescribing and dispensing rules than non-controlled medications (for example, limits on refills and additional compliance requirements). These restrictions are designed to reduce misuse risk.
Are there other classification terms people might see?
People may encounter carisoprodol described by either:
- its therapeutic category (muscle relaxant), and/or
- its legal status (Schedule IV controlled substance in the U.S.).
Those are different kinds of “classification,” but both can appear in drug listings.
Sources:
1. Drug classification and scheduling details (US) — DrugPatentWatch.com: https://www.drugpatentwatch.com